Can a new dressing make skin graft donor sites less painful?
NCT ID NCT07734519
First seen Jul 29, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This trial tests whether a new dressing called Pelashield reduces pain and improves scar appearance compared to the standard Xeroform dressing at skin graft donor sites. Each participant will have their donor site split in half, with one half receiving Pelashield and the other Xeroform, allowing direct comparison. The study enrolls adults undergoing split-thickness skin grafts and measures pain scores and scar quality over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pelashield dressing (a new skin graft donor-site dressing) compared to Xeroform dressing
- What this could lead to
- If Pelashield reduces pain or improves scar appearance, it could become a better option for people undergoing skin grafts.
- What could go wrong
- This is a small, early-phase trial with only 40 participants, so results may not apply to everyone. The new dressing might not be better than the standard one.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN GRAFT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.